Total | CW | Non-CW | p-value | |
---|---|---|---|---|
(n = 332) | (n = 190) | (n = 142) | ||
Age | 55 ± 13 | 54 ± 13 | 56 ± 13 | 0.263 |
Age ≥ 75 years | 13 (15.2%) | 5 (12.5%) | 8 (5.6%) | 0.490 |
Male gender | 278 (83.7%) | 160 (84.2%) | 118 (83.1%) | 0.785 |
HTN | 200 (60.2%) | 115 (60.5%) | 85 (59.9%) | 0.902 |
CHF | 22 (6.6%) | 14 (7.4%) | 8 (5.6%) | 0.518 |
DM2 | 48 (14.5%) | 26 (13.7%) | 22 (15.5%) | 0.644 |
Vascular disease | 140 (42.2%) | 79 (41.6%) | 61 (43.0%) | 0.801 |
CHA2DS2Vasc > 1 | 162 (48.8%) | 86 (45.3%) | 76 (53.5%) | 0.136 |
CHA2DS2Vasc, median (IQR) | 1 (1, 3) | 1 (1, 2) | 2 (1, 4) | 0.702 |
Prior CVA/TIA | 16 (4.8%) | 9 (4.7%) | 7 (4.9%) | 0.935 |
Post-PVI CVA | 4 (1.2%) | 4 (2.1%) | 0 (0.0%) | 0.034 |
Anticoagulation | ||||
Warfarin | 201 (69.6%) | 123 (73.7%) | 78 (63.9%) | 0.055 |
NOAC | 88 (30.4%) | 44 (26.3%) | 44 (36.1%) | 0.055 |
Aspirin | 43 (13.0%) | 23 (12.1%) | 20 (14.1%) | 0.589 |
Pre-procedure INRa | 2.2 ± 0.5 | 2.2 ± 0.5 | 2.2 ± 0.5 | 0.432 |
Rhythm prior to PVI | ||||
Sinus rhythm | 161 (48.8%) | 88 (46.8%) | 73 (51.4%) | 0.407 |
Atrial Arrhythmia | 166 (50.3%) | 97 (51.6%) | 69 (48.6%) | 0.589 |
Paced | 3 (0.9%) | 3 (1.6%) | 0 (0%) | 0.131 |
Follow-up, mo., median (IQR) | 72 (49, 97) | 73 (49, 107) | 69 (50, 92) | 0.344 |